Core/Unit Introduction

革新的統合バイオ研究コア

Advanced Health Care Science Research Unit

Interdisciplinary research to develop theories and methods for the recovery, maintenance and promotion of human tissue viability

Specialty:health science science of nursing science of infectious diseases

Keyword:tissue viability opportunistic infectious diseases microbes host response epidemiology microbiome

/ Professor

SUGAMA Junko

Researcher ID
Researcher Information

Research Content

Until today, medical sciences including nursing have been largely responsible for developing the treatment and prevention of diseases. This includes early diagnosis of the vulnerability to diseases (risk factors) as well as delayed recovery (prognosis factors), and their prevention. These sciences must be further developed as long as diseases prevail. Our bodies are able to maintain life and repair themselves; it is important that our life styles are appropriate to maintain these functions. In an era of increasing longevity, such abilities weaken with age and symptoms arise associated with the deterioration of body functions. This occurs even in the absence of illness, and brings about inconveniences in daily life. Utmost utilization of our ability to live a healthy life, depending on age and condition, is necessary, but insufficient research has been carried out to support such adaptation processes. This Research Unit aims to establish the science of health care for recovery, preservation and improvement of human life and survival, by promoting the integration of research areas of health sciences and related sciences. More specifically, we focus on infectious diseases caused by microbes (mainly on our skin and on oral and nasal cavity mucous membranes) and on their mechanisms of etiology and severity progression. In addition, by investigating health conditions of human subjects and their life styles, we aim to elucidate important factors related to etiology and severity progression. We also aim to assess disorders caused by various symptoms of infectious diseases (itchiness, edema, pain, odor, etc.) as well as to conduct studies on alleviation and improvement of such disorders. We are developing evaluation technologies, not only non-invasive but also readily clinically applicable, for those having vulnerable tissues.